Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/01/2009WO2009118174A1 Substituted cyclohexyldiamines
10/01/2009WO2009118173A1 Substituted spirocyclic cyclohexane derivatives
10/01/2009WO2009118171A1 Hydroxymethylcyclohexyl amines
10/01/2009WO2009118169A1 Spiro(5.5)undecane derivatives
10/01/2009WO2009118168A1 Substituted 4-aminocyclohexane derivatives
10/01/2009WO2009118167A1 Pharmaceutical formulation comprising a solid dispersion and method for the production thereof
10/01/2009WO2009118163A1 (hetero-)aryl cyclohexane derivatives
10/01/2009WO2009117987A2 Use of boswellia acids and synthetic boswellia acid derivatives for inhibiting microsomal prostanglandin e2 synthase and cathepsin g
10/01/2009WO2009117985A1 Pirinixic acid derivatives as prostglandin e2 synthesis inhibitors for treating inflammatory diseases
10/01/2009WO2009117902A1 5-demethoxyfumagillol and derivatives thereof
10/01/2009WO2009117899A1 The polymorphs of 4-anilinoquinazoline derivatives, the preparation methods and uses thereof
10/01/2009WO2009117888A1 Phosphodiesterase iii inhibitors, preparation methods and medical uses thereof
10/01/2009WO2009117831A1 Hybrid molecules having mixed vitamin d receptor agonism and histone deacetylase inhibitory properties
10/01/2009WO2009117829A1 Methods for synthesizing kotalanol and stereoisomers and analogues thereof, and novel compounds produced thereby
10/01/2009WO2009117828A1 Saponin extract from saponaria spp. and uses thereof
10/01/2009WO2009117819A1 Methylphenidate extended release therapeutic drug delivery system
10/01/2009WO2009117808A1 Inhibitors of histone deacetylase
10/01/2009WO2009117793A1 Composition and method for the inhibition of postoperative adhesions severity
10/01/2009WO2009117769A1 Inhibition of c-kit cancers
10/01/2009WO2009100181A3 Absorbent ingestible agents and associated methods of manufacture and use
10/01/2009WO2009100011A3 Targeted cellular selectivity of surface active molecules
10/01/2009WO2009099716A9 Novel vaccines against multiple subtypes of dengue virus
10/01/2009WO2009099489A3 Compositions and methods for improving cardiovascular health
10/01/2009WO2009098082A3 Antiinfective and antitumoral compounds isolated from tropical lianas
10/01/2009WO2009097973A3 Imidazopyridazines as par1 inhibitors, production thereof, and use thereof as medicaments
10/01/2009WO2009097287A9 Compounds and compositions as kinase inhibitors
10/01/2009WO2009095454A3 Method for the identification of patients in need of therapy having minor cognitive disorders and the treatment of such patients
10/01/2009WO2009095399A3 Pyrazine derivatives and their use as protein kinase inhbitors
10/01/2009WO2009095162A8 Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals
10/01/2009WO2009094563A3 Crystalline form of calcium-salts of (3s)-aminomethyl-b-methyl-hexanoic acids and methods of use
10/01/2009WO2009094191A3 Methods of treating viral infections
10/01/2009WO2009094190A3 Methods of treating viral infections
10/01/2009WO2009093253A3 Compositions and methods for modulating vascular endothelial growth factor c (vegf-c) expression
10/01/2009WO2009091964A3 Method for treating addiction using quercetin-containing compositions
10/01/2009WO2009091346A3 Stable pharmaceutical formulation and preparation methods
10/01/2009WO2009090556A8 Artificial reproduction of pharmaceutical conditions of dependency to tobacco and other addictive drugs (opiacea, psychostimulants, alcohol) by combination of nicotine and a ligand (agonist or 5 antagonist) of 5-ht1a receptors
10/01/2009WO2009089361A3 Systems methods and formulation for topically treating nail fungal infection and nail psoriasis
10/01/2009WO2009088192A3 Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect
10/01/2009WO2009080828A3 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
10/01/2009WO2009080638A3 Sulfamides as zap-70 inhibitors
10/01/2009WO2009080555A3 Carboxyl- or hydroxyl- substituted benzimidazole derivatives
10/01/2009WO2009079797A9 Compounds and method for treatment of cancer
10/01/2009WO2009079767A9 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer
10/01/2009WO2009077484A3 A cyano piperidinyl-phenil-oxazolidinone and use thereof.
10/01/2009WO2009074300A3 Hedgehog pathway antagonists and therapeutic applications thereof
10/01/2009WO2009073665A4 Acid mimic compounds for the inhibition of isoprenyl-s-cysteinyl methyltransferase
10/01/2009WO2009071452A3 Reduction of the adhesion of dirt, dust and biological material by means of polyester amides
10/01/2009WO2009065922A3 Organic compounds
10/01/2009WO2009065919A3 Organic compounds
10/01/2009WO2009061448A9 Methods and compositions for the treatment of proteinuric diseases
10/01/2009WO2009060835A8 Novel ubiquilin-binding small molecule
10/01/2009WO2009056707A3 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof
10/01/2009WO2009049648A3 Improved pharmaceutical composition containing antiviral agent and method for the preparation thereof
10/01/2009WO2009047216A3 Use of indolocarbazole imides as protein kinase inhibitors for the treatment of hematologic and solid tumors
10/01/2009WO2009045515A4 Antimicrobial and antiviral composition
10/01/2009WO2009043987A9 Antibiotic compositions containing essential oils, prophylaxis and treatment of nosocomial diseases
10/01/2009WO2008147763A8 Mmp inhibitors and methods of use thereof
10/01/2009WO2008108689A8 Mix for identification test in the process of quality control of the medicine 'glycine tablets for sublingual applying 0,1g' methods of its preparation and identity evaluation in the process of quality control of the aforementioned medicine
10/01/2009WO2008097561A8 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
10/01/2009WO2008008541A8 Methods to elicit, enhance and sustain immune responses against mhc class-i restricted epitopes, for prophylactic or therapeutic purposes
10/01/2009US20090249519 Immunization of fish with plant-expressed recombinant proteins
10/01/2009US20090249500 System for monitoring bacterial tumor treatment
10/01/2009US20090248316 Method for supporting a diagnosis of an effect of a treatment by using anthracycline anticancer drugs and a device for supporting a diagnosis for an effect of a treatment by using anthracycline anticancer drugs
10/01/2009US20090248097 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
10/01/2009US20090247778 Star polymer such as of a polylactone based on a central phosphorus atom derived from phosphorus oxychloride (POCl3) or ethyl dichlorophosphate; biodegradable and/or biocompatible; sustained release drug delivery; reverse thermal gelation
10/01/2009US20090247741 Process for the production of multiple cross-linked hyaluronic acid derivatives
10/01/2009US20090247733 Novel Bone Mineralization Proteins, DNA, Vectors, Expression Systems
10/01/2009US20090247731 Boronic ester and acid compounds, synthesis and uses
10/01/2009US20090247647 Method of Stimulating Proteoglycan Synthesis in Cells
10/01/2009US20090247646 Use of resveratrol and derivatives thereof for promoting the wellness state in mammals
10/01/2009US20090247645 Stabilized compositions of alkylating agents and methods of using same
10/01/2009US20090247644 Memantine formulations
10/01/2009US20090247643 Medicinal herbal composition for treating infection
10/01/2009US20090247642 Synthesis and preparations of metoprolol and its salts
10/01/2009US20090247641 Hydrazone agents to treat cutaneous lesions
10/01/2009US20090247640 Antimicrobials having polyquaternary ammoniums and alcohol-bearing amidoamines and methods for their use
10/01/2009US20090247639 Sulfonic acid and aldehyde condensation polymers for the treatment and prevention of hpv
10/01/2009US20090247638 Pharmaceutical use of cox-2-inhibitors in angiogenesis-mediated ocular disorders
10/01/2009US20090247637 Novel Anthranilic Acid Derivatives
10/01/2009US20090247636 Agent for suppression of gastric emptying comprising 4-hydroxyisoleucine
10/01/2009US20090247635 Method for treating anal pruritis and other perianal disorders
10/01/2009US20090247634 Methods for identifying modulators of eoxin formation
10/01/2009US20090247633 Nutrient extracts derived from green plant materials
10/01/2009US20090247632 Dermatological compositions and methods
10/01/2009US20090247631 Enzymatic Production Of Peracids Using Perhydrolytic Enzymes
10/01/2009US20090247630 Dermatological compositions comprising at least one naphthoic acid compound and at least one film-forming agent and treatment of keratinization disorders therewith
10/01/2009US20090247629 Dimer poly-quaternary ester compounds
10/01/2009US20090247628 Substituted phenylcyclohexylglycolates
10/01/2009US20090247627 Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
10/01/2009US20090247626 Method of Treating Dyslipidemia Using Naturally Occurring Diterpene
10/01/2009US20090247625 Compositions containing lignan-class compounds
10/01/2009US20090247624 Formulations of radioprotective alpha beta unsaturated aryl sulfones
10/01/2009US20090247623 Derivatives of epirubicin, their medicinal application and pharmaceuticaly acceptable forms of drugs
10/01/2009US20090247622 Natural topical compositions for the prevention and treatment of diaper rashes and related conditions
10/01/2009US20090247621 Diosmetin compounds, a process for their preparation and pharmaceutical composition containing them
10/01/2009US20090247620 Benzochromene Derivatives for Use in Liquid Crystal Media and as Therapeutic Active Substances
10/01/2009US20090247619 Cannabinoid-Containing Compositions and Methods for Their Use
10/01/2009US20090247618 Process for preparation of benzo-fused heteroaryl derivatives
10/01/2009US20090247617 Process for the preparation of benzo-fused heteroaryl sulfamates
10/01/2009US20090247616 Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety
1 ... 2552 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 ... 7860